Skip to main content
Equibles
EPRX logo

EPRX · Eupraxia Pharmaceuticals Inc.

Track EPRX — free

Use EPRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.43 -0.25 (-3.67%)
Rebalance outlook locked
Market Cap
$441.04M
Shares
66.07M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

EPRX Short Interest Forecast

Equibles' model estimates 6,646,257 shares sold short for the August 31, 2026 settlement, +4.9% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
6,646,257 +4.9% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
82/100
Short interest 9.6% of shares — P89 Days to cover 28.8 — P97 Price vs VWAP +2.4% — P62 Short-volume trend +57.1% — P99 Short interest change +4.9% — P68 Worst FTD 0.01% of shares — P50

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 6,336,985 6,043,489 +293,496 28.76
    2026-07-31 6,043,489 5,921,701 +121,788 12.99
    2026-07-15 5,921,701 5,462,325 +459,376 25.74
    2026-06-30 5,462,325 4,597,670 +864,655 8.99
    2026-06-15 4,597,670 4,078,992 +518,678 16.27
    2026-05-29 4,078,992 3,561,791 +517,201 12.26
    2026-05-15 3,561,791 3,076,432 +485,359 23.75
    2026-04-30 3,076,432 2,568,242 +508,190 17.77
    2026-04-15 2,568,242 2,541,747 +26,495 16.35
    2026-03-31 2,541,747 2,500,950 +40,797 10.48
    2026-03-13 2,500,950 1,979,996 +520,954 11.76
    2026-02-27 1,979,996 1,658,534 +321,462 5.81
    2026-02-13 1,658,534 1,471,385 +187,149 9.03
    2026-01-30 1,471,385 1,441,076 +30,309 9.47
    2026-01-15 1,441,076 1,311,773 +129,303 7.80
    2025-12-31 1,311,773 549,299 +762,474 7.65
    2025-12-15 549,299 422,094 +127,205 5.65
    2025-11-28 422,094 251,763 +170,331 2.69
    2025-11-14 252,163 265,495 -13,332 1.37
    2025-10-31 265,495 256,174 +9,321 5.13
    2025-10-15 256,174 296,130 -39,956 4.30
    2025-09-30 296,130 185,235 +110,895 1.00
    2025-09-15 185,235 183,350 +1,885 12.61

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1581178 CUSIP 29842P105 13F (30d) 68 filings 66 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)